Trial Profile

A Phase 2 Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in T1DM Subjects

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 09 Oct 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Oct 2024 Results comparing changes of weight, glycated haemoglobin, glycaemic patterns during continuous glucose monitoring, and insulin doses at baseline and at the end of treatment published in the Diabetes, Obesity and Metabolism
23 Sep 2022 Primary endpoint (Body weight change from baseline to week 16 of treatment) has been met according to results presented at the 58th Annual Meeting of the European Association for the Study of Diabetes.
23 Sep 2022 Results assessing efficacy and safety of ADO09 versus insulin lispro in people with type 1 diabetes presented at the 58th Annual Meeting of the European Association for the Study of Diabetes.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com